Andreas Gollner

8PUBLICATIONS
48CO-AUTHORS
Molecular targetsOrganometallic chemistryBiologically active moleculesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 19, 2024
Targeting cancer with small-molecule pan-KRAS degraders.

Johannes Popow, William Farnaby, Andreas Gollner

|Sep 11, 2024
Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2-p53 Antagonist Suitable for Intermittent Dose Schedules.

Andreas Gollner, Dorothea Rudolph, Ulrike Weyer-Czernilofsky

|Feb 05, 2024
Synthesis of Indazoles via N-N Bond-Forming Oxidative Cyclization from 2-Aminomethyl-phenylamines.

Anna Schoeggl Toledano, Jacqueline Bitai, David Covini

|Feb 24, 2023
Kinase Degraders, Activators, and Inhibitors: Highlights and Synthesis Routes to the Chemical Probes on opnMe.com, Part 1.

Andreas Gollner, Claudia Heine, Karin S Hofbauer

|Oct 27, 2022
Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRASG12C Inhibitor.

Joachim Bröker, Alex G Waterson, Chris Smethurst

|Aug 29, 2022
Synthesis of MDM2-p53 Inhibitor BI-0282 via a Dipolar Cycloaddition and Late-Stage Davis-Beirut Reaction.

Juergen Ramharter, Michael Kulhanek, Maike Dettling

Pageof 2

Frequent Collaborators

4 joint publications

Harald Weinstabl

3 joint publications

Darryl B McConnell

2 joint publications

Dirk Kessler

2 joint publications

Jürgen Ramharter